Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate

European Journal of Endocrinology

Volumn 160, Issue 1, 2009, Pages 81-86

  Verrotti, Alberto ^a   Laus, Melissa ^a   Scardapane, Alessandra ^a   Franzoni, Emilio ^b   Chiarelli, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LIOTHYRONINE; PROTIRELIN; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; VALPROIC ACID; ANTICONVULSIVE AGENT;

ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; LIOTHYRONINE BLOOD LEVEL; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROTIRELIN TEST; SIDE EFFECT; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; BLOOD; DRUG ADMINISTRATION; DRUG EFFECT; PROSPECTIVE STUDY; STATISTICAL MODEL; THYROID GLAND;

ANTICONVULSANTS; CARBAMAZEPINE; CHILD; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; FEMALE; HUMANS; LINEAR MODELS; MALE; PROSPECTIVE STUDIES; THYROID GLAND; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; VALPROIC ACID;

EID: 58249089954     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0325     Document Type: Article

References (45)

1. Loiseau P. Carbamazepine: clinical efficacy and use in epilepsy. In Antiepileptic Drugs, edn 5, ch 23, pp 262-272. Eds RH Levy, RH Mattsson, BS Meldrum & E Perucca, Philadelphia: Lippincott Williams & Wilkins, 2002.
2. Eadie MJ & Tyrer JH. Carbamazepine. In Anticonvulsant Therapy-Pharmacological Basis and Practice, 3rd edn, pp 142-154. Oxford: Churchill Livingstone, 1989.
3. Bourgeois BFD. Valproic acid: clinical efficacy and use in epilepsy. In Antiepileptic Drugs, edn 5, ch 23, pp 808-817. Eds RH Levy, RH Mattsson, BS Meldrum & E Perucca, Philadelphia: Lippincott Williams & Wilkins, 2002.
4. De Silva M, McArdle B & McGowan M. Randomized comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996 347 709-713.
5. Isojärvi JIT, Pakarinen AJ, Yipalosaari PJ & MyllyIa VV. Serum hormones in male epileptic patients receiving anticonvulsant medication. Archives of Neurology 1990 47 670-676.
6. Murialdo G, Galimberti CA, Fonzi S, Manni R, Costelli P & Parodi C. Sex hormones, gonadotropins, and prolacticn in male epileptic subjects in remission. Role of the epileptic syndrome and antiepileptic treatment. Neuropsychobiology 1994 30 29-36.
7. Pack A. Effects of treatment of endocrine function in patients with epilepsy. Current Treatment Options in Neurology 2005 7 273-280.
8. Ciampani M, Verrotti A & Chiarelli F. Sex hormones in patients with epilepsy. Hormonal changes in epileptic men and woman taking antiepileptics. Hormone and Metabolic Research 2005 37 184-188.
9. Verrotti A, Basciani F, Morrresi S, Morgese G & Chiarelli F. Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatric Neurology 2001 25 43-46.
10. Eirìs-Puňal J, Del Rìo-Garma M, Del Rìo-Garma MC, Lojo-Rocamonde S, Novo-Rodrìguez I & Castro-Gago M. Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 1999 40 1761-1766.
11. Vainionpää LK, Mikkonen K, Rättyä J, Knip M, Pakarinen AJ, Myllylä VV & Isojärvi JIT. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia 2004 45 197-203.
12. Isojärvi JIT, Pakarinen AJ & Myllylä VV. Thyroid function with antiepileptic drugs. Epilepsia 1992 33 142-148.
13. Cannacher AA, Borsey DQ, Browning MC, Davidson DL & Jung RT. The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic. Journal of Postgraduate Medicine 1987 63 831-851.
14. Zhu S, Liu X, Ruan X & Cai Z. Changes of thyroid hormone levels in epileptic patients. Journal of Tongji Medical University 1994 14 119-123.
15. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989 30 389-399.
16. Rapaport R, Sills I, Patel U, Oppenheimer E, Skura K, Horlick M, Goldstein S, Dimartino J & Saenger P. Thyrotropin-releasing hormone stimulating tests in infants. Journal of Clinical Endocrinology and Metabolism 1993 4 889-894.
17. Herzog AG, Coleman AE, Jacobs AR, Klein P, Friedman MN, Drislane FW, Ransil BJ & Schomer DL. Interictal EEG discharge, reproductive hormones disorders in epilepsy. Annals of Neurology 2003 54 625-637.
18. Kuba R, Pohanka M, Zàkopcan J, Novatnà I & Rektor I. Sexual dysfunctions and blood hormonal profile in men with focal epilepsy. Epilepsia 2006 47 2135-2140.
19. Surks MI & Sievert R. Drugs and thyroid function. New England Journal of Medicine 1995 333 1688-1693.
20. Haidukewych D & Rodin EA. Chronic antiepileptic drugs therapy: classification by medication regimen and incidence of decreases in serum thyroxine and free thyroxine index. Therapeutic Drug Monitoring 1987 9 392-398.
21. Ericsson UB, Bjerre I, Forsgren M & Ivarsson SA. Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine, and valproic acid. Epilepsia 1985 26 594-596.
22. Isojärvi JIT, Pakarinen AJ & MyllyIä VV. Thyroid function in epileptic patients treated with carbarmazepine. Archives of Neurology 1989 46 1175-1178.
23. Tiihonen M, Liewendahl K, Waltimo O, Ojala M & Valimaki M. Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: a placebo-controlled thyroxine therapy trial. Epilepsia 1995 36 810-816.
24. Surks MI & DeFesi CR. Normal serum free thyroid hormone concentrations in patients treatedwithphenytoinor carbamazepine. Journal of the American Medical Association 1996 275 1495-1498.
25. Bentsen KD, Gram L & Veje A. Serum thyroid hormones and blood folic acid during monotherapy with carbarmazepine or valproate. Acta Neurologica Scandinavica 1983 67 235-241.
26. Cannell JMC, Rapeport WG, Gordon S & Brodie MJ. Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine. European Journal of Clinical Pharmacology 1984 26 453-456.
27. Isojärvi JIT, Airaksinen KEJ, Mustonen JN, Pakarinen AJ, Rautio A, Pelkonen O & Myllylä VV. Thyroid and myocardial function after replacing carbamazepine by oxcarbazepine. Epilepsia 1995 36 810-816.
28. Tanaka K, Koda Ma S, Yokoyama S, Komatsu M, Konishi H, Momota K & Matsuo T. Thyroid function in children with longterm anticonvulsant treatment. Journal of Pediatric Neurosciences 1987 13 90-94.
29. Larkin JG, MacPhee GJA, Beastall GH & Brodie MJ. Thyroid hormone concentrations in epileptic patients. European Journal of Clinical Pharmacology 1989 36 213-216.
30. Isojärvi JIT, Turkka J, Pakarinen AJ, KotilaM, Rättyä J & Myllyä VV. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 2001 42 930-934.
31. Cansu A, Serdaroǧlu A, Çamurdan O, Hirfanöglu T, Bideci A & Gücüyener K. The evaluation of thyroid function, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate. Epilepsia 2007 47 1855-1859.
32. Mikati MA, Tarabay H, Khalil A, Rahi AC, El Banna D & Najjar S. Risk factors for development of subclinical hypothyroidism during valproic acid therapy. Journal of Pediatrics 2007 151 178-181.
33. Gidal BE, Anderson GD, Spencer NW, Maly MM, Murty J, Pitterle ME, Collins DM & Davies LA. Valproate associated weight gain: potential relation to energy expenditure and metabolism in patients with epilepsy. Journal of Epilepsy 1996 9 234-241.
34. Fleischher N, Burgus R, Vale W, Dunn T & Guillemin R. Preliminary observations on the effect of synthetic thyrotropin-releasing factor on plasma thyrotropin levels in man. Journal of Clinical Endocrinology and Metabolism 1970 31 109-112.
35. Haigler ED, Pittman JA, Hershman JM & Baugh CM. Direct evaluation of pituitary thyrotropin reserve utilizing synthetic thyrotropin-releasing hormone. Journal of Clinical Endocrinology and Metabolism 1971 33 573-581.
36. Kaplan SL, Grumbach MM, Friesen HG & Costom BH. Thyrotropin-releasing factor effect on secretion of human pituitary prolactin and thyotropin in children and in idiopathic hypopituitary dwarfism: further evidence for hypophysiotropic hormone deficiencies. Journal of Clinical Endocrinology and Metabolism 1972 35 825-830.
37. Faglia G, Beck-Peccoz P, Ambrosi B, Ferrari C & Neri V. Prolonged and exaggerated elevations in plasma thyrotropin after thyrotropin-releasing factor in patients with pituitary tumors. Journal of Clinical Endocrinology and Metabolism 1971 33 999-1002.
38. Costom BH, Grumbach MM & Kaplan SL. Effect of thyrotropin-releasing factor on serum thyroid-stimulating hormone. An approach to distinguishing hypothalamic from pituitary forms of idiopathic hypopituitary dwarfism. Journal of Clinical Investigation 1971 50 2219-2225.
39. Hall R, Ormston BJ, Besser GM & Cryer RJ. The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet 1972 i 759-763.
40. Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travaglini P & Paracchi S. Plama thyrotropin rensponse to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. Journal of Clinical Endocrinology and Metabolism 1973 37 595-601.
41. Gruneiro de Papendiecck L, Iorcansky S, Rivarola MA, Heinrich JJ & Bergada C. Patterns of TSH response to TRH in children with hypopituitarism. Journal of Pediatrics 1982 100 387-392.
42. Milner RD & Herber SM. Response to TRH in suspected hypopituitarism. Archives of Disease in Childhood 1983 58 195-197.
43. Blank DW & Joffe RT. Effect of carbamazepine on thyroid hormone measurement in vitro. Clinica Chimica Acta 1984 143 173-176.
44. Joffert RT, Gold PW, Uhde TW & Post RM. The effects of carbamazepine on the thyrotropin response to thyrotrophin-releasing hormone. Psychiatry Research 1984 12 161-166.
45. Dana-Haeri J, Oxley J & Richens A. Pituitary responsiveness to gonadotrophin-releasing and thyrotrophin-releasing hormones in epileptic patients receiving carbamazepine or phenytoin. Clinical Endocrinology 1984 20 163-176.